Data Factory
Reading the graph
Reading the graph
Venture Capital
Andover, MA
Averin is a multi-stage investment firm working with outstanding management teams to help their organizations thrive and create a lasting impact on…
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Averin SPV I LLC | 2024 | Early deployment | $3.0M | $3.0M | 0 |
| Averin Health Opportunities Fund I LP | 2024 | Early deployment | $167M | $175M | 0 |
| Averin SPV II LLC | 2024 | Early deployment | $600,000 | $600,000 | 0 |
| Averin Capital Fund II-A LP | n/a | Fundraising | $0 | n/a | 0 |
| Averin SPV III LLC | n/a | Fundraising | $0 | n/a | 0 |
| Averin Capital Fund II LP | n/a | Fundraising | $0 | n/a | 0 |
Also named here, with no published line of their own (reach them through the firm): Todd Ruppert (Former CEO & President, T. Rowe Price GIS), David Berry (Managing Partner), Eric Berry (Managing Partner), Tristan Hunt (Partner), Jeffrey Low (Partner), Tomer Zitelny (Partner), Alex Lau (Partner & Chief Operating Officer), Amy Therattil (Chief of Staff), Oanh Sam (Director, Operations & Experience), Steve Bolze (Former CEO, GE Healthcare; Former CEO, GE Power), Mikael Dolsten (Former Chief Scientific Officer, Pfizer), Roland Diggelmann (Former CEO, Roche Diagnostics).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan